LOGIN TO YOUR ACCOUNT

Username
Password
Remember Me
Or use your Academic/Social account:

CREATE AN ACCOUNT

Or use your Academic/Social account:

Congratulations!

You have just completed your registration at OpenAire.

Before you can login to the site, you will need to activate your account. An e-mail will be sent to you with the proper instructions.

Important!

Please note that this site is currently undergoing Beta testing.
Any new content you create is not guaranteed to be present to the final version of the site upon release.

Thank you for your patience,
OpenAire Dev Team.

Close This Message

CREATE AN ACCOUNT

Name:
Username:
Password:
Verify Password:
E-mail:
Verify E-mail:
*All Fields Are Required.
Please Verify You Are Human:
fbtwitterlinkedinvimeoflicker grey 14rssslideshare1
Teixeira, Dania Sofia da
Languages: English
Types: Doctoral thesis
Subjects:

Classified by OpenAIRE into

mesheuropmc: nervous system
In the developing peripheral nervous system, neuronal survival and axonal growth are regulated by a variety of factors, the most extensively studied of which are secreted neurotrophic factors. To identify additional candidate molecules involved in regulating these aspects of neuronal development, I carried out a PCR screen for the expression of transcripts encoding receptors and selected ligands of three important superfamilies ligands and receptors (Wnt, TGF-beta and TNF) over a broad range of developmental ages in three experimentally tractable populations of PNS neurons of mice (superior cervical ganglion, nodose ganglion and trigeminal ganglion). From these screening results I selected one member of the TGF-beta superfamily (growth differentiation factor 5, GDF5), and one of the TNF receptor superfamily (B Cell Maturation Antigen, BCMA). These studies have revealed that GDF5 is synthesized in sympathetic targets and promotes sympathetic axon growth and branching independently of NGF when these axons are ramifying in their distal targets. Mice lacking GDF5 have major deficiencies in sympathetic innervation without loss of neurons, indicating that target-derived GDF5 is essential for establishing appropriate tissue innervation during development. Function blocking antibodies against BCMA and one of its ligands, BAFF, markedly impair the ability of NGF to promote the survival of cultured sympathetic neurons from the SCG ganglion at the postnatal age of PO. Similarly, blocking the functions of BCMA and its other ligand, TACI, also leads to impaired survival, but at the earlier age of El 5. These findings reveal novel regulators of axonal growth and neuronal survival in developing peripheral nervous system.
  • The results below are discovered through our pilot algorithms. Let us know how we are doing!

    • 3.5.2 TGF-p superfamily______________________________________________________ 96 4.1 Introduction_____________________________________________________________ 136 5.1 Introduction_____________________________________________________________ 163 thalamus. Liu C, W ang Y, Smallwood PM, Nathans J. 2008, J Neurosci, pp. 28(22):5641-53.
    • 402. Frizzledr3 is requiredfo r the development o f major fiber tracts in the rostral CNS. W ang Y, Thekdi N, Sm allw ood PM , M acke JP, Nathans J. 2002, J Neurosci, pp. 22(19):8563-73.
    • 403. Anterior-posterior guidance o f commissural axons by Wnt-frizzled signaling. Lyuksyutova AI, Lu CC, M ilanesio N , K ing LA, Guo N, W ang Y , Nathans J, Tessier-Lavigne M , Zou Y. 2003, Science, pp. 302(5652): 1984-8.
    • 404. Wnt signaling through Dishevelled, Rac and JNK regulates dendritic development. Rosso SB, Sussman D, W ynshaw -Boris A , Salmas PC.
    • 2005, Nat Neurosci, pp. 8(l):34-42.
    • 405. Increased expression o f Wnt-1 in schizophrenic brains. M iyaoka T, Seno H, Ishino H. 1999, Schizophr Res, pp. 38(1): 1-6.
    • 406. Mfrp, a gene encoding a frizzled related protein, is mutated in the mouse retinal degeneration 6. K am eya S, Hawes NL, Chang B, Heckenlively JR , N aggert JK , Nishina PM.
    • 2002, Hum Mol Genet, pp. 11(16): 1879-86.
    • 407. The Wnt-1 (int-1) proto-oncogene is required fo r development o f a large region o f the mouse brain M cM ahon A P, Bradley A. 1990, Cell, pp.
    • 408. Targeted disruption o f the murine int-1 proto-oncogene resulting in severe abnormalities in midbrain and cerebellar development. Thomas KR, Capecchi M R. 1990, Nature, pp.
    • 409. A local Wnt-3a signal is required fo r development o f the mammalian hippocampus. Lee SM , Tole S, G rove E, M cM ahon AP. 2000, Development, pp. 127(3):457-67.
    • 410. Hippocampus development and generation o f dentate gyrus granule cells is regulated by LEF1.
    • Galceran J, M iyashita-Lin EM , Devaney E, Rubenstein JL, Grosschedl R. 2000, Development, pp. 127(3):469-82.
    • 411. Wnt signalling required fo r expansion o f neural crest and CNS progenitors. Ikeya M, Lee SM, Johnson JE, McMahon AP, Takada S.
    • 1997, Nature, pp. 389(6654):966-70.
    • 412. Evidence fo r a mitogenic effect o f Wnt-1 in the developing mammalian central nervous system. Dickinson M E, Krum lauf R, McMahon AP. 1994, Development, pp. 120(6): 1453-71.
    • 413. The bone morphogenetic protein type lb receptor is a major mediator o f glial differentiation and cell survival in adult hippocampal progenitor cell culture. Brederlau A, Faigle R , Elmi M, Zarebski A, Sjoberg S, Fujii M , M iyazono K, Funa K. 2004, Mol Biol Cell, pp. 15(8):3863-75.
    • 414. TGF-(beta}l activates two distinct type I receptors in neurons: implications fo r neuronal NF-{kappa}B signaling. K5nig HG, K6gel D, Ram i A, Prehn JH. 2005, J Cell Biol, pp.
    • 415. Defective ALK5 signaling in the neural crest leads to increased postmigratory neural crest cell apoptosis and severe outflow tract defects. W ang J, Nagy A, Larsson J, Dudas M , Sucov HM , Kaartinen V . 2006, BMC Dev B io l, p. 6:51.
    • 416. Alternative neural crest cell fates are instructively promoted by TGFbeta superfamily members. Shah N M , Groves AK, Anderson DJ.
    • 1996, Cell, pp. 85(3):331-43.
    • 417. Culture conditions determine the prevalence o f bipolar and monopolar neurons in cultures o f dissociated spiral ganglion. W hitlon DS, Grover M , Tristano J, W illiams T, Coulson M T. 2007, Neuroscience, pp. 146(2):833-40.
    • 418. Osteogenic protein-1 induces dendritic growth in rat sympathetic neurons. Lein P, Johnson M , Guo X , Rueger D, Higgins D. 1995, Neuron, pp. 15(3):597-605.
    • 419. Bone morphogenetic protein-7 enhances dendritic growth and receptivity to innervation in cultured hippocampal neurons. W ithers GS, Higgins D, Charette M , Banker G. 2000, Eur J Neurosci, pp. 12(1):106-16.
    • 421. Tumor Necrosis Factor {alpha} Regulates Responses to Nerve Growth Factor, Promoting Neurcd Cell Survival but Suppressing Differentiation o f Neuroblastoma Cells. Takei Y, Laskey R^. 2008, Mol Biol Cell, pp. 19(3):855- 64.
    • 422. TNF-alpha pretreatment induces protective effects against fo ca l cerebral ischemia in mice.
    • Nawashiro H, Tasaki K, Ruetzler CA, Hallenbeck JM . 1997, J Cereb Blood Flow Metab, pp. 17(5):483-90.
    • 423. Tumor necrosis factor-alpha modulates the proliferation o f neural progenitors in the subventricular/ventricular zone o f adult rat brain.
    • Wu JP, Kuo JS, Liu YL, Tzeng SF. 2000, Neurosci L ett., pp. 292(3):203-6.
    • 424. TNFalpha contributes to the death o f NGFdependent neurons during development. Barker V, M iddleton G , Davey F, Davies AM . 2001, Nat Neurosci, pp. 4(12): 1194-8.
    • 425. NGF-promoted axon growth and target innervation requires G1TRL-GITR signaling.
    • O'Keeffe GW , G utierrez H, Pandolfi PP, Riccardi C , Davies AM . 2008, Nat Neurosci, pp.
    • 426. Neutralization o f TRAIL death pathway protects human neuronal cell line from betaamyloid toxicity. Cantarella G, Uberti D, Carsana T, Lom bardo G , Bernardini R, Memo M. 2003, Cell Death Diffe, pp. 10(1): 134-41.
    • 427. The role o f TNF related apoptosis-inducing ligand in neurodegenerative diseases. Huang Y, Erdmann N, Peng H, Zhao Y, Zheng J. 2005, Cell Mol Immunol, pp. 2(2): 113-22.
    • 428. Molecular regulation o f CD40 gene expression in macrophages and microglia.
    • 2004, Brain Behav Immun, pp. 18(1):7-12.
    • 429. Role o f WNT signaling in normal and malignant hematopoiesis. Khan NI, Bendall LJ.,.
    • 2006, Histol Histopathol., pp. 21(7):761-74.
    • 430. Mutant Frizzled 4 associated with vitreoretinopathy traps wild-type Frizzled in the endoplasmic reticulum by oligomerization.
    • Kaykas A, Yang-Snyder J, Heroux M , Shah K V , Bouvier M , M oon RT. 2004, Nat Cell B io l., pp. 6(l):52-8.
    • 431.. The Wnt receptor FZD1 mediates chemoresistance in neuroblastoma through activation o f the Wnt/beta-catenin pathway.
    • Junl 1;28(23) 2245-56, 2009.
    • 432. Expression o f Wnt genes andfrizzled 1 and 2 receptors in normal breast epithelium and infiltrating breast carcinoma. M ilovanovic T, Planutis K, Nguyen A, Marsh JL, Lin F, Hope C , Holcom be RFJnt J Oncol. Nov;25(5):1337- 42., 2004.
    • 433. A role fo r frizzled 3 in neural crest development. Deardorff MA, Tan C, SaintJeannet JP, Klein PS. 2001, Development., pp.
    • 434. The human frizzled-3 (FZD3) gene on chromosome 8p21, a receptor gene fo r Wnt ligands, is associated with the susceptibility to schizophrenia Katsu T, Ujike H, Nakano T, Tanaka Y, Nomura A, Nakata K, Takaki M, Sakai A, Uchida N, Imamura T, Kuroda S.
    • 2003, Neurosci L ett., pp. 353(1 ):53-6.
    • 435. Progressive cerebellar, auditory, and esophageal dysfunction caused by targeted disruption o f the frizzled-4 gene. W ang Y, Huso D , Cahill H, Ryugo D, Nathans J. J. Neurosci.
    • Jul 1;21(13):4761-71,2001.
    • 436. An essential role fo r FrizzledS in neuronal survival in the parafascicular nucleus o f the thalamus. Liu C, W ang Y, Smallwood PM, Nathans J~7 Neurosci. May 28;28(22):5641-53, 2008.
    • 437. Frizzled6 controls hair patterning in mice.
    • Guo N, Hawkins C , Nathans J. Proc Natl Acad Sci USA. . Jun 22;101(25):9277-81, 2004.
    • 438. The role o fFrizzled3 and Frizzled6 in neural tube closure and in the planar polarity o f innerear sensory hair cells. W ang Y , Guo N, Nathans iJN eurosci. Feb 22;26(8):2147-56,2006.
    • 439. Variable FZD7 expression in colorectal cancers indicates regulation by the tumour microenvironment. Vincan £ , Flanagan DJ, Pouliot N, Brabletz T , Spaderna S.Dev Dyn.
    • Aug 4., 2009.
    • 440. Frizzled9 protein is regionally expressed in the developing medial cortical wall and the cells derived from this region. Zhao C, Pleasure SJ.Brain Res Dev Brain Res. . Jun 9;157(l):93-7, 2005.
    • 441. Head inducer Dickkopf-1 is a ligandfo r Wnt coreceptor LRP6. Sem enov M V, Tam ai K, Brott BK, Kuhl M , Sokol S, H e X. 2001, Curr Biol. , pp. 11(12):951-61.
    • 442. Kremen proteins interact with Dickkopfl to regulate anteroposterior CNS patterning.
    • Davidson G, M ao B, del Barco Barrantes I, Niehrs C. 2002, Development, pp. 129(24):5587- 96.
    • 443. Expression o f receptor tyrosine kinase RYK in developing rat central nervous system.
    • 1999, Brain Res D ev Brain R e s ., pp. 114(1):149- 60.
    • 444. Cell-type-specific expression o f protein tyrosine kinase-related receptor RYK in the central nervous system o f the rat. Kamitori K, Machide M , Tomita K, Nakafuku M , Kohsaka S. 2002, Brain Res Mol Brain Res. , pp.
    • 445. Mammalian Ryk is a Wnt coreceptor requiredfo r stimulation o f neurite outgrowth. Lu W , Yamamoto V , Ortega B, Baltim ore D. 2004, Cell, pp. 119(1):97-108.
    • 446. Ryk: a novel Wnt receptor regulating axon pathfinding. Keeble TR, Cooper HM.V 2006, Int J Biochem Cell B io l., pp. 38(12):2011-7.
    • 447. The functions and possible significance o f Kremen as the gatekeeper o f Wnt signalling in development and pathology. Nakamura T, Nakamura T, Matsumoto K. J Cell Mol M ed .
    • Apr,12(2):391-408,2008.
    • 448. Extracellular regulation o f BMP signaling in vertebrates: a cocktail o f modulators. Balemans W , Van Hul W .„ 2002, Dev Biol. , pp.
    • 449. DRAGON, a bone morphogenetic protein coreceptor. Samad TA, Rebbapragada A, Bell £ , Zhang Y , Sidis Y, Jeong SJ, Campagna JA, Perusini S, Fabrizio DA, Schneyer AL, Lin HY, Brivanlou AH, Attisano L, W oolf CJ. 2005, J B iol Chem., pp. 280(14): 14122-9.
    • 450. Controlling the angiogenic switch: a balance between two distinct TGF-b receptor signaling pathways. Goumans M J, Lebrin F, Valdim arsdottir G. Trends Cardiovasc M ed .
    • 451. Activin receptor-like kinase 1 inhibits human microvascular endothelial cell migration: potential roles fo r JNK and ERK. David L, M allet C, Vailh6 B, Lamouille S, Feige JJ, Bailly S J Cell Physiol. 213(2):484-9, 2007.
    • 452. Truncated activin type II receptors inhibit bioactivity by the formation o f heteromeric complexes with activin type I. receptors. De W inter JP, De Vries CJ, Van Achterberg TA, Am eerun RF, Feijen A, Sugino H, De W aele P, H uylebroeck D, Verschueren K, Van Den Eijden-Van Raaij AJ. Exp Cell Res.
    • 453. Identification o f BMP9 and BMP10 as functional activators o f the orphan activin receptor-like kinase 1 (ALK1) in endothelial cells.
    • David L, M allet C, Mazerbourg S, Feige JJ, Bailly SM lood 1;109(5): 1953-61,2007.
    • 454. Activin receptor-like kinase 2 and Smad6 regulate epithelial-mesenchymal transformation 460. Characterization o f bone morphogenetic protein-6 signaling pathways in osteoblast differentiation. Ebisawa T, Tada K, Kitajima I, Tojo K, Sampath TK , Kawabata M , Miyazono K, Imamura T. J Cell Sci. 112 ( Pt 20):3519-27, 1999.
    • 461. Identification o f type I and type II serine/threonine kinase receptors fo r growth/differentiation factor-5. Nishitoh H, Ichijo H, Kimura M , M atsum oto T, M akishima F, Yamaguchi A , Yam ashita H, Enomoto S, Miyazono K. 1996, J Biol Chem., pp.
    • 479. Growth/differentiation factor 5 enhances chondrocyte maturation. Coleman CM , Tuan RS.Z>ev Dyn. 228(2):208-16,2003.
    • 480. Effects o f growth/differentiation factor-5 on human periodontal ligament cells. Nakamura T, Yam am oto M , Tamura M , Izumi Y. J Periodontal Res. 38(6):597-605,2003.
    • 481. APP binds DR6 to trigger axon pruning and neuron death via distinct caspases. Nikolaev A, M cLaughlin T, O'Leary DD, Tessier-Lavigne M. Nature. 457(7232):981-9,2009.
    • 482. Molecular crosstalk between TRAIL and natural antioxidants in the treatment o f cancer.
    • 483. A novel role o f CD30L/CD30 signaling by TT cell interaction in Thl response against mycobacterial infection. Tang C, Yamada H, Shibata K, M uta H, Wajjwalku W, Podack ER, Yoshikai \ J Immunol. 181(9):6316-27,2008.
    • 484. Structure and expression o f murine CD30 and its role in cytokine production. Bowen M A, Lee RK, M iragliotta G, Nam SY, Podack E R J Im m unol.. 156(2):442-9,1996.
    • 485. Tumor necrosis factor/tumor necrosis factor receptor fam ily members that positively regulate immunity. So T, Lee SW , Croft M Jnt J Hematol.
    • 486. Signaling by death receptors in the nervous system. Haase G, Pettmann B, Raoul C, Henderson CE.Curr Opin Neurobiol. 18(3):284- 91,2008.
    • 487. Fas ligand and Fas are expressed constitutively in human astrocytes and the expression increases with IL-1, IL-6, TNF-alpha, or IFN-gamma. Choi C, Park JY, Lee J, Lim JH, Shin EC, Ahn YS, Kim CH, Kim SJ, Kim JD , Choi IS, Choi IH. J Immunol. 162(4):1889- 95,1999.
    • 502. CD40 and CD154 in cell-mediated immunity.
    • Grewal IS, Flaveil RA. 1998, Annu Rev Immunol., pp. 16:111-35.
    • 503. CD40-CD40 ligand interactions in experimental allergic encephalomyelitis and multiple sclerosis. Gerritse K, Laman JD, Noelle RJ, Aruffo A, Ledbetter JA , Boersma WJ, Claassen E. 1996, Proc Natl Acad Sci U S A . , pp. 93(6):2499-504.
    • 504. Microglial activation resulting from CD40- CD40L interaction after beta-amyloid stimulation.
    • Tan J, Town T, Paris D, M ori T, Suo Z, Crawford F, M attson M P, Flavell RA, Mullan M. 1999, Science, pp. 286(5448):2352-5.
    • 505. Induction o f cycloaxygenase-2 in reactive glial cells by the CD40 pathway: relevance to amyotrophic lateral sclerosis. Okuno T, Nakatsuji Y, Kum anogoh A , Koguchi K, Moriya M, Fujim ura H, Klkutani H, Sakoda S.
    • 2004, J Neurochem ., pp. 91(2):404-12.
    • 506. Ligation o f CD40 stimulates the induction o f nitric-oxide synthase in microglial cells. Jana M, Liu X, Koka S, Ghosh S, Petro TM , Pahan K.
    • 2001, J Biol C hem ., pp. 276(48):44527-33.
    • 507. The mitogen-inducible F nl4 gene encodes a type I transmembrane protein that modulates fibroblast adhesion and migration. M eighanMantha RL, Hsu DK, G uo Y, Brown SA, Feng SL, Peifley KA, Alberts G F, Copeland NG, Gilbert DJ, Jenkins NA, Richards CM, W inkles JA . 1999, J Biol Chem. , pp.
    • 508. Pro-inflammatory effect o f TWEAK/Fnl4 interaction on human umbilical vein endothelial cells. Harada N, Nakayam a M , Nakano H, Fukuchi Y, Yagita H, Okumura K. 2002, Biochem Biophys Res Commun., pp. 299(3):488- 93.
    • 509. TWEAK induces angiogenesis and proliferation o f endothelial cells. Lynch CN, W ang YC, Lund JK , Chen YW , Leal JA , W iley SR. 1999, J Biol C hem ., pp. 274(13):8455-9.
    • 510. The human F nl4 receptor gene is upregulated in migrating glioma cells in vitro and overexpressed in advanced glial tumors. Tran NL, McDonough W S, Donohue PJ, W inkles JA, Berens TJ, Ross KR, Hoelzinger DB, Beaudry C, Coons SW , Berens M E. 2003, Am J Pathol., pp. 162(4): 1313-21.
    • 511. Fibroblast growth factor-inducible-14 is induced in axotomized neurons and promotes neurite outgrowth. Tanabe K, Bonilla I, W inkles JA, Strittmatter SM. 2003, J Neurosci. , pp.
    • 514. BAFF, APRIL and their receptors: structure, function and signaling. Bossen C, Schneider P.,.
    • 2006, Semin Immunol., pp. 18(5):263-75.
    • 515. Ectodysplasin signaling in development.
    • M ikkola M L, Thesleff I. Cytokine Growth Factor Rev. 14(3-4):211-24,2003.
    • 516. Myodegeneration in EDA-A2 transgenic mice is prevented by XEDAR deficiency. Newton K , French DM , Yan M , Frantz GD, Dixit VM.
    • 2004, Mol Cell B io l., pp. 24(4):1608-13.
    • 517. Expression o f a member o f tumor necrosis factor receptor superfamily, TROY, in the developing mouse brain. Hisaoka T, Morikawa Y , Kitamura T, Senba E. Brain Res Dev Brain Res. 143(l):105-9,2003.
    • 518. Troy/Taj and its role in CNS axon regeneration. M i S. Cytokine Growth Factor Rev.
    • 519. Differential inhibition o f TRAIL-mediated DR5-DISC formation by decoy receptors I and 2.
    • M 6rino D, Lalaoui N, M orizot A, Schneider P, Solary E, M icheau O. Mol Cell Biol. 6(19):7046- 55, 2006.
    • 520. Crucial role fo r BAFF-BAFF-R signaling in the survival and maintenance o f mature B cells.
    • PLoS One. 4(5):e5456, 2009.
    • 521. TNF fam ily member B cell-activating factor (BAFF) receptor-dependent and -independent roles fo r BAFF in B cell physiology. Sasaki Y, Casola S, K utok JL , Rajewsky K , SchmidtSupprian M. J Immunol. 173(4):2245-52, 2004.
    • 529. APRIL is overexpressed in cancer: link with tumor progression. Moreaux J, Veyrune JL, De Vos J, Klein B. BMC Cancer. 9:83,2009.
    • 530.. TNF signaling inhibition in the CNS: implications fo r normal brain Junction and neurodegenerative disease. McCoy MK, Tansey M G J Neuroinflammation. 5:45,2008.
    • 531. Involvement o f tumor necrosis factor alpha in hippocampal development andJunction. Golan H , Levav T, Mendelsohn A, Huleihel M. Cereb cortex. 14(1):97-105,2004.
    • 532. Mice transgenic fo r BAFF develop lymphocytic disorders along with autoimmune manifestations. M ackay F, W oodcock SA, Lawton P, Am brose C, Baetscher M, Schneider P, Tschopp J, Browning J L J exp Med.
    • 533. TWEAK and the central nervous system.
    • Yepes M. Mol Neurobiol. 35(3):255-65,2007.
    • Heuckeroth R , Johnson E, M ilbrandt J. 2002, Neuron, pp. 35(2):267-82.
    • 539. Endothelins are vascular-derived axonal guidance cues fo r developing sympathetic neurons. M akita T, Sucov HM , Gariepy CE, Yanagisawa M , G inty DD. Nature.
    • 540. Joint patterning defects caused by single and double mutations in members o f the bone morphogenetic protein (BMP) fam ily. Storm EE, Kingsley DM . 1996, Development, pp.
    • 541. The role o f growth/differentiation factor 5 (GDF5) in the induction and survival o f midbrain dopaminergic neurones: relevance to Parkinson's disease treatment. Sullivan A M , O 'K eeffe GW.V 2005, J A n a t, pp. 207(3):219-26.
    • 542. Cartilage-derived morphogenetic proteins.
    • Chang SC, H oang B, Thom as JT, Vukicevic S, Luyten FP, Ryba N J, K ozak CA, Reddi AH, Moos M Jr. 1994, J Biol Chem. , pp.
    • 543. Bone morphogenetic proteins regulate interdigital cell death in the avian embryo.
    • Merino R, G afiin Y, M acias D, RodriguezLe6n J, Hurle JM . 1999, Ann N Y Acad Sci. , pp. 887:120-32.
    • 544. The anatomy and development o f brachypodism in the mouse. Grunenberg H, Lee AJ,. 1973, J Embryol Exp Morphol, pp. 30:119- 41.
    • 545. Growth and survival signals controlling sympathetic nervous system development.
    • Glebova NO, Ginty DD. 2005, Annu Rev Neurosci., pp. 28:191-222.
    • 546. NGF signalingfrom clathrin-coated vesicles: evidence that signaling endosomes serve as a platform fo r the Ras-MAPK pathway. Howe CL, Valletta JS, Rusnak AS, M obley W C. 2001, Neuron, pp. 32(5):801-14.
    • 550. Bone morphogenetic proteins and their antagonists. Gazzerro E, Canalis E. 2006, Rev Endocr Metab Disord, pp. 7(l-2):51-65.
    • 551. Intracellular BMP signaling regulation in vertebrates: pathway or network? von Bubnoff A , Cho KW . 2001, Dev B io l., pp. 239(1):1-14.
    • 552. TGF-beta signaling: a tale o f two responses.
    • Rahim i RA, L eof EB. 2007, J Cell Biochem ., pp.
    • 553. Upregulation o f ID protein by growth and differentiation factor 5 (GDF5) through a smaddependent and MAPK-independent pathway in HUVSMC. Chen X , Zankl A, Niroomand F, Liu Z, Katus HA, Jahn L, Tiefenbacher C. 2006, J Mol Cell Cardiol, pp. 41(l):26-33.
    • 554. Limb alterations in brachypodism mice due to mutations in a new member o f the TGF betasuperfamily. Storm EE, Huynh TV, Copeland NG, Jenkins NA, Kingsley DM , Lee SJ. 1994, Nature, pp. 368(6472):639-43.
    • 555. NGF-promoted axon growth and target innervation requires GITRL-GITR signaling.
    • O 'Keeffe GW , Gutierrez H, Pandolfi PP, R iccardi C , Davies AM. 2008, Nat Neurosci. , pp. 11(2): 135-42.
    • 556. Low-affinity nerve growth factor receptor p75NTR immunoreactivity in the myocardium with sympathetic hyperinnervation. Zhou S, Cao JM , Swissa M , Gonzalez-Gomez I, Chang CM, 564. Signalling pathways o f the TNF superfamily: a double-edged sword Aggarwal, BB. 2003, Nat Rev Immunol, pp. 3(9):745-56.
    • 565. BAFF: a fundamental survival factor fo r B cells. Mackay F, Browning JL.,. 2002, Nat Rev Immunol, pp. 2(7):465-75.
    • 566. BAFF AND APRIL: a tutorial on B cell survival. M ackay F, Schneider P, Rennert P, Browning J.r 2003, Annu Rev Immunol, pp.
    • 567. B cells and the BAFF/APRIL axis: fastforw ard on autoimmunity and signaling. Mackay F, Silveira PA, Brink R.,. 2007, Curr Opin Immunol, pp. 19(3):327-36.
    • 568. Peripheral target regulation o f dendritic geometry in the rat superior cervical ganglion.
    • Voyvodic JT. 1989, J Neurosci., pp. 9(6):1997- 2010.
    • 569. Extracellular stimuli specifically regulate localized levels o f individual neuronal mRNAs.
    • 570. Identification and characterization o f nuclearfactor kappaB binding sites in the murine bcl-x promoter. Glasgow JN, W ood T, PerezPolo JR. 2000, J Neurochem., pp. 75(4): 1377-89.
    • 571. Regulation o f Al/Bfl-1 expression in peripheral splenic B cells. Trescol-Bifrnont MC, Verschelde C, Cottalorda A, Bonnefoy-Blrard N. 2004, B iochim ie., pp. 86(4-5):287-94.
    • 572. Trk receptors use redundant signal transduction pathways involving SHC and PLCgamma 1 to mediate NGF responses. Stephens RM , Loeb DM, Copeland TD, Pawson T, Greene LA, Kaplan DR. 1994, Neuron, pp.
    • 573. Neurotrophins: roles in neuronal development andfunction. Huang EJ, Reichardt LF. 2001, Annu Rev Neurosci., pp. 24:677-736.
    • 575. Early days o f the nerve growth factor proteins. Shooter EM . 2001, Annu Rev Neurosci.
    • , pp. 24:601-29.
    • 585. TNF receptor subtype signalling: differences and cellular consequences. DJ., MacEwan. 2002, Cell Signal., pp. 14(6):477-92.
    • 586. APRIL, a new ligand o f the tumor necrosis factor family, stimulates tumor cell growth.
    • Hahne M , Kataoka T, Schroter M , Hofmann K , Irm ler M , Bodmer JL, Schneider P, Bornand T, Holler N, French LE, Sordat B, Rimoldi D, Tschopp J. 1998, J Exp Med., pp.
    • 587. NF-AT activation induced by a CAMLinteracting member o f the tumor necrosis factor receptor superfamily, von Bulow GU, Bram RJ.,.
    • 1997, Science, pp. 278(5335):138-41.
    • 588. BAFF-R, a newly identified TNF receptor that specifically interacts with BAFF. Thompson JS, Bixler SA, Qian F, Vora K, Scott ML, Cachero TG, Hession C, Schneider P, Sizing ID , M ullen C, Strauch K, Zafari M , Benjamin C D , Tschopp J, Browning JL, Ambrose C.
    • 2001, Science, pp. 293(5537):2108-11.
    • 589. Identification o f a novel receptor fo r B lymphocyte stimulator that is mutated in a mouse strain with severe B cell deficiency. Yan M, Brady JR, Chan B, Lee W P, Hsu B, Harless S, Cancro M , Grewal IS, Dixit VM. 2001, Curr B io l., pp. 11(19): 1547-52.
    • 590. A new gene, BCM, on chromosome 16 is fu sed to the interleukin 2 gene by a t(4;16)(q26;pl3) translocation in a malignant T cell lymphoma. Laabi Y, Gras M P, Carbonnel F, Brouet JC , Berger R, Larsen CJ, Tsapis A.
    • 1992, EMBO J., pp. 11(11):3897-904.
    • 591. Identification o fproteoglycans as the APRILspecific binding partners. Ingold K, Zumsteg A, Tardivel A , Huard B, Steiner QG, Cachero TG, Qiang F, Gorelik L, R ailed SL, Acha-Orbea H, Rennert PD, Tschopp J, Schneider P. 2005, J Exp M ed ., pp. 201(9):1375-83.
    • 593. The role o f APRIL and BAFF in lymphocyte activation. Schneider P. 2005, Curr Opin Immunol., pp. 17(3):282-9.
    • 602. BAFF-induced NEMO-independent processing o f NF-kappa B2 in maturing B cells.
    • Claudio E, Brown K, Park S, W ang H, Siebenlist U. 2002, Nat Immunol., pp. 3(10):958- 65.
    • 603. IkappaB kinase alpha is essentialfo r mature B cell development and junction. Kaisho T, Takeda K, Tsujimura T, Kawai T, Nomura F, Terada N, Akira S. 2001, J Exp Med., pp.
    • 604. Requirement fo r NF-kappaB in osteoclast and B-cell development. Franzoso G, Carlson L, Xing L, Poljak L, Shores EW , Brown KD, Leonardi A , Tran T, Boyce BF, Siebenlist U.
    • 1997, Genes Dev, pp. ll(24):3482-96.
    • 605. NF-kappa B1 p50 is required fo r BLyS attenuation o f apoptosis but dispensable for processing o f NF-kappa B2 p i 00 to p52 in quiescent mature B cells. Hatada EN, Do RK, Orlofsky A, Liou HC, Prystowsky M, M acLennan IC, Caamano J, Chen-Kiang S.
    • 2003, J Im m unol., pp. 171(2):761-8.
    • 606. Role o f NF kappa B activator A ctl in CD40- mediated signaling in epithelial cells. Qian Y, Zhao Z, Jiang Z, Li X.,. 2002, Proc Natl Acad Sci U S A . , pp. 99(14):9386-91.
    • 607. Targeted disruption o f TRAF3 leads to postnatal lethality and defective T-dependent immune responses. Xu Y, Cheng G, Baltimore D. 1996, Immunity, pp. 5(5):407-15.
    • 608. Regulation o f the NF-kappaB-inducing kinase by tumor necrosis factor receptorassociatedfactor 3-induced degradation. Liao G, Zhang M, Harhaj EW , Sun SC. 2004, J Biol C hem ., pp. 279(25):26243-50.
    • 619. Mechanisms o f TGF-beta signalingfrom cell membrane to the nucleus. Shi Y, Massague J.
    • 2003, Cell, pp. 113(6):685-700.
    • 620. Cytostatic and apoptotic actions o f TGF-beta in homeostasis and cancer. Siegel PM, Massague J. 2003, Nat Rev Cancer, pp. 3(11):807-21.
    • 621. Two major Smad pathways in TGF-beta superfamily signalling. Miyazawa K, Shinozaki M , Hara T, Furuya T, Miyazono K. 2002, Genes Cells, pp. 7(12): 1191-204.
    • 622. TGF-beta signaling in tumor suppression and cancer progression. Derynck R, Akhurst RJ, Balmain A. 2001, Nat Genet, pp. 29(2): 117- 29.
    • 623. Bone morphogenetic proteins. Chen D, Zhao M , M undy GR. 2004, Growth Factors, pp.
    • 624. What MAN1 does to the Smads.
    • TGFbeta/BMP signaling and the nuclear envelope. Bengtsson, L. 2007, FEBS J, pp.
    • 625. Reduced genomic 5-methylcytosine content in human colonic neoplasia. Feinberg AP, Gehrke CW , Kuo KC, Ehrlich M. 1988, Cancer Res, pp. 48(5): 1159-61.
    • 641. Molecular cloning and characterization o f LR3, a novel LDL receptor fam ily protein with mitogenic activity. Dong Y, Lathrop W , Weaver D , Qiu Q , Cini J, Bertolini D, Chen D. 1998, Biochem Biophys Res Commun., pp. 251(3):784- 90.
    • 645. A new secreted protein that binds to Wnt proteins and inhibits their activities. Hsieh JC, Kodjabachian L, Rebbert M L, Rattner A, Smallwood PM , Sam os CH , N usse R, Dawid IB, Nathans J. 1999, Nature, pp. 398(6726):431- 6.
    • 647. The head inducer Cerberus is a multifunctional antagonist o f Nodal, BMP and Wnt signals. Piccolo S, Agius E, Leyns L, Bhattacharyya S, Grunz H , Bouwmeester T, De Robertis EM. 1999, Nature, pp. 397(6721):707- 10.
    • 705. The nerve growth factor family. Barde YA.
    • 1990, Prog Growth Factor R e s., pp. 2(4):237-48.
    • Inohara N.v 1998, Oncogene , pp. 17(25):3237- 45.
    • 767. Apoptosis in the nervous system. Yuan J, Yankner BA.V 2000, Nature, pp. 407(6805):802- 9.
    • 773. Living in context with the survival factor BAFF. Cancro MP. 2008, Immunity., pp.
    • 28(3):300-l.
  • No related research data.
  • No similar publications.

Share - Bookmark

Cite this article